Adaptive Biotechnologies Corp Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 110,000 | |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 125,000 | |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.68 | 2,147 | 121,692 | 0 | 2.1 K to 0 (-100.00 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 55.96 | 9,420 | 527,143 | 2,147 | 11.6 K to 2.1 K (-81.44 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 54.96 | 3,433 | 188,678 | 10,567 | 14 K to 10.6 K (-24.52 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.99 | 1,700 | 101,983 | 0 | 1.7 K to 0 (-100.00 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.37 | 6,913 | 410,425 | 1,700 | 8.6 K to 1.7 K (-80.26 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.19 | 6,387 | 371,660 | 8,613 | 15 K to 8.6 K (-42.58 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Option Exercise | M | 7.80 | 40,000 | 312,000 | 341,250 | |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 60.01 | 8,268 | 496,163 | 0 | 8.3 K to 0 (-100.00 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 59.24 | 14,233 | 843,163 | 8,268 | 22.5 K to 8.3 K (-63.25 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 58.22 | 17,499 | 1,018,792 | 22,501 | 40 K to 22.5 K (-43.75 %) |
| Jan 29 2021 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Buy | M | 7.80 | 40,000 | 312,000 | 40,000 | 0 to 40 K |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 57.83 | 2,300 | 133,009 | 1,739,780 | 1.7 M to 1.7 M (-0.13 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 57.32 | 4,300 | 246,476 | 1,742,080 | 1.7 M to 1.7 M (-0.25 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 55.94 | 2,800 | 156,632 | 1,746,380 | 1.7 M to 1.7 M (-0.16 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 55.01 | 600 | 33,006 | 1,749,180 | 1.7 M to 1.7 M (-0.03 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.72 | 1,875 | 111,975 | 1,749,780 | 1.8 M to 1.7 M (-0.11 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.79 | 3,246 | 190,832 | 1,751,655 | 1.8 M to 1.8 M (-0.18 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 57.71 | 2,000 | 115,420 | 1,754,901 | 1.8 M to 1.8 M (-0.11 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 56.26 | 1,000 | 56,260 | 1,756,901 | 1.8 M to 1.8 M (-0.06 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 54.63 | 1,879 | 102,650 | 1,757,901 | 1.8 M to 1.8 M (-0.11 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 65.23 | 100 | 6,523 | 1,759,780 | 1.8 M to 1.8 M (-0.01 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 64.52 | 3,526 | 227,498 | 1,759,880 | 1.8 M to 1.8 M (-0.20 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.63 | 2,524 | 160,602 | 1,763,406 | 1.8 M to 1.8 M (-0.14 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.51 | 3,850 | 240,664 | 1,765,930 | 1.8 M to 1.8 M (-0.22 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 165,000 | |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 215,000 | |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 65.47 | 5,920 | 387,582 | 1,000 | 6.9 K to 1,000 (-85.55 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 64.54 | 20,785 | 1,341,464 | 6,920 | 27.7 K to 6.9 K (-75.02 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 63.65 | 12,977 | 825,986 | 27,705 | 40.7 K to 27.7 K (-31.90 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.71 | 10,318 | 647,042 | 40,682 | 51 K to 40.7 K (-20.23 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 67.68 | 1,000 | 67,680 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 67.03 | 17,436 | 1,168,735 | 2,000 | 19.4 K to 2 K (-89.71 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 65.69 | 20,953 | 1,376,403 | 19,436 | 40.4 K to 19.4 K (-51.88 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 65.08 | 10,611 | 690,564 | 40,389 | 51 K to 40.4 K (-20.81 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 140,000 | |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 155,000 | |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.90 | 600 | 39,540 | 0 | 600 to 0 (-100.00 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.28 | 3,470 | 226,522 | 600 | 4.1 K to 600 (-85.26 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.32 | 10,930 | 703,018 | 4,070 | 15 K to 4.1 K (-72.87 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 67.79 | 500 | 33,895 | 0 | 500 to 0 (-100.00 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 67.05 | 8,816 | 591,113 | 500 | 9.3 K to 500 (-94.63 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.89 | 1,813 | 119,459 | 9,316 | 11.1 K to 9.3 K (-16.29 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.09 | 3,871 | 251,963 | 11,129 | 15 K to 11.1 K (-25.81 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 23,370 | 147,698 | 210,330 | |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.59 | 2,100 | 141,939 | 679 | 2.8 K to 679 (-75.57 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.90 | 17,329 | 1,159,310 | 2,779 | 20.1 K to 2.8 K (-86.18 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.06 | 3,941 | 260,342 | 20,108 | 24 K to 20.1 K (-16.39 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 23,370 | 147,698 | 24,049 | 679 to 24 K (+3,441.83 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 170,000 | |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 67.19 | 9,476 | 636,692 | 0 | 9.5 K to 0 (-100.00 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.23 | 5,524 | 365,855 | 9,476 | 15 K to 9.5 K (-36.83 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 185,000 | |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 67.63 | 45 | 3,043 | 0 | 45 to 0 (-100.00 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.87 | 8,511 | 569,131 | 45 | 8.6 K to 45 (-99.47 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.15 | 6,444 | 426,271 | 8,556 | 15 K to 8.6 K (-42.96 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 265,000 | |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 68.33 | 5,012 | 342,470 | 1,000 | 6 K to 1,000 (-83.37 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 67.35 | 33,938 | 2,285,724 | 6,012 | 40 K to 6 K (-84.95 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 66.82 | 11,050 | 738,361 | 39,950 | 51 K to 40 K (-21.67 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 71.14 | 100 | 7,114 | 1,769,780 | 1.8 M to 1.8 M (-0.01 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 70.42 | 8,300 | 584,486 | 1,769,880 | 1.8 M to 1.8 M (-0.47 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 315,000 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 70.66 | 6,889 | 486,777 | 1,000 | 7.9 K to 1,000 (-87.32 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 69.74 | 14,201 | 990,378 | 7,889 | 22.1 K to 7.9 K (-64.29 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 69.00 | 6,695 | 461,955 | 22,090 | 28.8 K to 22.1 K (-23.26 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 67.75 | 4,581 | 310,363 | 28,785 | 33.4 K to 28.8 K (-13.73 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 66.97 | 17,634 | 1,180,949 | 33,366 | 51 K to 33.4 K (-34.58 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 133,700 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 183,700 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 68.20 | 4,661 | 317,880 | 679 | 5.3 K to 679 (-87.28 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.39 | 24,945 | 1,681,044 | 5,340 | 30.3 K to 5.3 K (-82.37 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.84 | 20,394 | 1,363,135 | 30,285 | 50.7 K to 30.3 K (-40.24 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 50,000 | 316,000 | 50,679 | 679 to 50.7 K (+7,363.77 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 70.75 | 2,100 | 148,575 | 679 | 2.8 K to 679 (-75.57 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 69.97 | 8,052 | 563,398 | 2,779 | 10.8 K to 2.8 K (-74.34 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 69.26 | 5,701 | 394,851 | 10,831 | 16.5 K to 10.8 K (-34.48 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.74 | 3,001 | 203,288 | 16,532 | 19.5 K to 16.5 K (-15.36 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.02 | 31,146 | 2,087,405 | 19,533 | 50.7 K to 19.5 K (-61.46 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 50,000 | 316,000 | 50,679 | 679 to 50.7 K (+7,363.77 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 200,000 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 215,000 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 68.34 | 6,370 | 435,326 | 0 | 6.4 K to 0 (-100.00 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 67.58 | 4,264 | 288,161 | 6,370 | 10.6 K to 6.4 K (-40.10 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.49 | 4,366 | 290,295 | 10,634 | 15 K to 10.6 K (-29.11 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 71.23 | 200 | 14,246 | 0 | 200 to 0 (-100.00 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 70.51 | 4,822 | 339,999 | 200 | 5 K to 200 (-96.02 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 69.54 | 7,415 | 515,639 | 5,022 | 12.4 K to 5 K (-59.62 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 68.72 | 2,563 | 176,129 | 12,437 | 15 K to 12.4 K (-17.09 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 4.07 | 23,000 | 93,610 | 27,000 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 2,000 | 1,680 | 0 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 69.00 | 25,000 | 1,725,000 | 10,000 | 35 K to 10 K (-71.43 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | M | 4.07 | 23,000 | 93,610 | 35,000 | 58 K to 35 K (-39.66 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 2,000 | 1,680 | 12,000 | 10 K to 12 K (+20.00 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 1,250 | |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 69.00 | 417 | 28,773 | 0 | 417 to 0 (-100.00 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 230,000 | |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 67.19 | 1,491 | 100,180 | 0 | 1.5 K to 0 (-100.00 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.47 | 8,802 | 585,069 | 1,491 | 10.3 K to 1.5 K (-85.51 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.47 | 4,707 | 308,167 | 10,293 | 15 K to 10.3 K (-31.38 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 57,000 | |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 67.05 | 622 | 41,705 | 0 | 622 to 0 (-100.00 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 66.34 | 1,378 | 91,417 | 622 | 2 K to 622 (-68.90 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 159,000 | |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 66.89 | 1,110 | 74,248 | 0 | 1.1 K to 0 (-100.00 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 66.12 | 890 | 58,847 | 1,110 | 2 K to 1.1 K (-44.50 %) |
| Jan 20 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 2,000 | 0 to 2 K |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 245,000 | |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 260,000 | |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.35 | 2,461 | 163,287 | 0 | 2.5 K to 0 (-100.00 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.48 | 12,539 | 821,054 | 2,461 | 15 K to 2.5 K (-83.59 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.72 | 6,885 | 438,712 | 0 | 6.9 K to 0 (-100.00 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.79 | 8,115 | 509,541 | 6,885 | 15 K to 6.9 K (-54.10 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 6,000 | 46,800 | 95,000 | |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 66.43 | 959 | 63,706 | 0 | 959 to 0 (-100.00 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 65.77 | 5,041 | 331,547 | 959 | 6 K to 959 (-84.02 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 6,000 | 46,800 | 6,000 | 0 to 6 K |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 365,000 | |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 63.63 | 34,180 | 2,174,873 | 1,000 | 35.2 K to 1,000 (-97.16 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.92 | 15,820 | 995,394 | 35,180 | 51 K to 35.2 K (-31.02 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 75,000 | 474,000 | 415,000 | |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 63.73 | 1,200 | 76,476 | 1,000 | 2.2 K to 1,000 (-54.55 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.96 | 33,827 | 2,129,748 | 2,200 | 36 K to 2.2 K (-93.89 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.25 | 39,973 | 2,488,319 | 36,027 | 76 K to 36 K (-52.60 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 75,000 | 474,000 | 76,000 | 1,000 to 76 K (+7,500.00 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 275,000 | |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 290,000 | |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.10 | 5,128 | 323,577 | 0 | 5.1 K to 0 (-100.00 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.47 | 9,872 | 616,704 | 5,128 | 15 K to 5.1 K (-65.81 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.74 | 9,756 | 602,335 | 0 | 9.8 K to 0 (-100.00 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.68 | 2,544 | 154,370 | 9,756 | 12.3 K to 9.8 K (-20.68 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.62 | 2,700 | 160,974 | 12,300 | 15 K to 12.3 K (-18.00 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 305,000 | |
| Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.35 | 4,944 | 303,314 | 0 | 4.9 K to 0 (-100.00 %) |
| Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | S | 60.44 | 6,186 | 373,882 | 4,944 | -1,242 to 4.9 K (-498.07 %) |
| Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.70 | 2,213 | 132,116 | 11,130 | 13.3 K to 11.1 K (-16.59 %) |
| Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.82 | 1,657 | 97,465 | 13,343 | 15 K to 13.3 K (-11.05 %) |
| Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 350,000 | |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 365,000 | |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.56 | 363 | 20,531 | 0 | 363 to 0 (-100.00 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 55.98 | 14,637 | 819,379 | 363 | 15 K to 363 (-97.58 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.40 | 709 | 42,115 | 0 | 709 to 0 (-100.00 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.09 | 4,751 | 275,986 | 709 | 5.5 K to 709 (-87.01 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.52 | 3,169 | 182,281 | 5,460 | 8.6 K to 5.5 K (-36.72 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.05 | 6,371 | 357,095 | 8,629 | 15 K to 8.6 K (-42.47 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 320,000 | |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 335,000 | |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.30 | 15,000 | 859,500 | 0 | 15 K to 0 (-100.00 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 55.45 | 808 | 44,804 | 0 | 808 to 0 (-100.00 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 54.86 | 14,192 | 778,573 | 808 | 15 K to 808 (-94.61 %) |
| Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | M | 6.32 | 10,000 | 63,200 | 35,000 | |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 59.46 | 400 | 23,784 | 0 | 400 to 0 (-100.00 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 58.67 | 592 | 34,733 | 400 | 992 to 400 (-59.68 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 57.76 | 5,725 | 330,676 | 992 | 6.7 K to 992 (-85.23 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 56.10 | 3,283 | 184,176 | 6,717 | 10 K to 6.7 K (-32.83 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Buy | M | 6.32 | 10,000 | 63,200 | 10,000 | 0 to 10 K |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 37,500 | |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 54,688 | |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 26,042 | |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 59.46 | 267 | 15,876 | 0 | 267 to 0 (-100.00 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 58.63 | 495 | 29,022 | 267 | 762 to 267 (-64.96 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 57.82 | 3,800 | 219,716 | 762 | 4.6 K to 762 (-83.30 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 56.12 | 2,209 | 123,969 | 4,562 | 6.8 K to 4.6 K (-32.62 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,771 | 5.2 K to 6.8 K (+30.01 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
| Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |